Acute Myeloid Leukemia in Remission

Known as: Acute Myeloblastic Leukemia in Remission, Acute Granulocytic Leukemia in Remission, Acute myeloid leukemia, in remission 
Acute myeloid leukemia not growing, responding to treatment.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
The effects of HLA-identical sibling donor (ISD) hematopoietic stem cell transplantation (HSCT) on adults with intermediate- or… Expand
  • table 1
  • figure 1
  • figure 1
  • table 2
Is this relevant?
2015
2015
The optimal intensity of conditioning for allogeneic hematopoietic stem cell transplantation (HCT) in acute myeloid leukemia (AML… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
The impact of risk-related parameters has not been defined in transplantation settings. We wondered whether the currently… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2006
2006
Relapse is a major obstacle in the cure of acute myeloid leukemia (AML). The Pediatric Oncology Group AML Study 9421 tested 2… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1997
1997
The presence of residual leukemic cells was studied using metaphase-fluorescence in situ hybridization (FISH) in 22 patients with… Expand
  • table 1
  • figure 1
Is this relevant?
Highly Cited
1990
Highly Cited
1990
We analyzed the relevance of HLA incompatibility to acute graft-versus-host disease, relapse, and survival in 281 patients with… Expand
Is this relevant?
1987
1987
A pilot study was conducted to determine the possible efficacy and the toxicities associated with the administration of four… Expand
Is this relevant?
1984
1984
The activity of erythrocyte superoxide dismutase (SOD) and catalase was determined in 38 patients with lung cancers (n = 15… Expand
Is this relevant?
1982
1982
1-beta-D-Arabinofuranosylcytosine (ara-C), 2 or 3 g/sq m, was administered as a 1-hr i.v. infusion every 12 hr for 10 or 12 doses… Expand
Is this relevant?